|

Arm A Clinical Trials

2 actively recruiting trials across 1 location

Also known as: S1, Tislelizumab

Pipeline

Phase 2: 2

Top Sponsors

  • Tianjin Medical University Cancer Institute and Hospital1
  • Fox Chase Cancer Center1

Indications

  • Cancer2
  • Non-Small Cell Carcinoma of Lung, TNM Stage 41
  • Esophageal Cancer1
  • Lung Cancer1

Other1 trial

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
Phase 2

Philadelphia, Pennsylvania1 trial

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Fox Chase Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.